These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9441069)

  • 1. Short-course chemoprophylaxis evaluated in gold miners with chronic silicosis.
    Hoeppner VH
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):89-90. PubMed ID: 9441069
    [No Abstract]   [Full Text] [Related]  

  • 2. Short course chemoprophylaxis with rifampicin, isoniazid and pyrazinamide for tuberculosis evaluated in gold miners with chronic silicosis: a double-blind placebo controlled trial.
    Cowie RL
    Tuber Lung Dis; 1996 Jun; 77(3):239-43. PubMed ID: 8758107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Compliance, tolerance and effectiveness of a short chemoprophylaxis regimen for the treatment of tuberculosis].
    Martínez Alfaro E; Solera J; Serna E; Cuenca D; Castillejos ML; Espinosa A; Sáez L
    Med Clin (Barc); 1998 Oct; 111(11):401-4. PubMed ID: 9834911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemoprophylaxis of tuberculosis (lecture)].
    Kovaleva SI
    Probl Tuberk; 1992; (1-2):39-42. PubMed ID: 1603790
    [No Abstract]   [Full Text] [Related]  

  • 5. Completing tuberculosis prophylaxis in jail: targeting treatment and a comparison of rifampin/pyrazinamide with isoniazid regimens.
    Lambert LA; Ijaz K; Navin TR
    Int J Tuberc Lung Dis; 2005 Feb; 9(2):230; author reply 230-1. PubMed ID: 15732748
    [No Abstract]   [Full Text] [Related]  

  • 6. Completing tuberculosis prophylaxis in jail: targeting treatment and comparison of rifampin/pyrazinamide with isoniazid regimens.
    Lincoln T; Brannan GL; Lynch V; Conklin TJ; Clancey T; Rose DN; Tuthill RJ
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):306-11. PubMed ID: 15139468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial experience on rifampin and pyrazinamide vs isoniazid in the treatment of latent tuberculosis infection among patients with silicosis in Hong Kong.
    Leung CC; Law WS; Chang KC; Tam CM; Yew WW; Chan CK; Wong MY
    Chest; 2003 Dec; 124(6):2112-8. PubMed ID: 14665488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term tuberculosis prophylaxis is effective in persons with HIV.
    Gordin F
    Am Fam Physician; 1998 Sep; 58(4):948. PubMed ID: 9767729
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-tubercular treatment regime for Musculoskeletal Tuberculosis.
    Pokharel RK
    JNMA J Nepal Med Assoc; 2006; 45(162):279-80. PubMed ID: 18365358
    [No Abstract]   [Full Text] [Related]  

  • 11. Silicotuberculosis: long-term outcome after short-course chemotherapy.
    Cowie RL
    Tuber Lung Dis; 1995 Feb; 76(1):39-42. PubMed ID: 7718845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparison of tuberculosis treatments: a short course therapy and the directly observed short course treatment (DOTS), East Java Province, Indonesia.
    Roosihermiatie B; Nishiyama M; Nakae K
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):85-8. PubMed ID: 11023071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term efficacy of full course intermittent short-course chemotherapy on new smear positive tuberculosis patients].
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Jun; 20(3):164-6. PubMed ID: 10072822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
    Dekker TG; Lötter AP
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases.
    Sneag DB; Schaaf HS; Cotton MF; Zar HJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1142-6. PubMed ID: 18043453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up.
    Su WJ; Perng RP
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1029-32. PubMed ID: 12475151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.
    Am Rev Respir Dis; 1992 Jan; 145(1):36-41. PubMed ID: 1731596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral solid lipid nanoparticle-based antitubercular chemotherapy.
    Pandey R; Sharma S; Khuller GK
    Tuberculosis (Edinb); 2005; 85(5-6):415-20. PubMed ID: 16256437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A short two-drug regimen prevents active TB.
    Torres G
    GMHC Treat Issues; 1998 Apr; 12(4):12. PubMed ID: 11365399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.